1177.HK vs. 6078.HK
Compare and contrast key facts about Sino Biopharmaceutical Ltd (1177.HK) and Hygeia Healthcare Holdings Co Ltd (6078.HK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: 1177.HK or 6078.HK.
Key characteristics
| 1177.HK | 6078.HK | |
|---|---|---|
| YTD Return | -22.77% | -11.47% |
| 1Y Return | -34.84% | -42.49% |
| 3Y Return (Ann) | -31.19% | -20.30% |
| Sharpe Ratio | -0.97 | -0.91 |
| Daily Std Dev | 41.82% | 53.65% |
| Max Drawdown | -87.72% | -81.32% |
| Current Drawdown | -85.93% | -70.99% |
Fundamentals
| 1177.HK | 6078.HK | |
|---|---|---|
| Market Cap | HK$43.97B | HK$17.87B |
| EPS | HK$0.01 | HK$0.00 |
| PE Ratio | 21.27 | 24.19 |
| Revenue (TTM) | HK$26.20B | HK$4.08B |
| Gross Profit (TTM) | HK$21.53B | HK$1.02B |
| EBITDA (TTM) | HK$6.31B | HK$1.00B |
Correlation
The correlation between 1177.HK and 6078.HK is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
1177.HK vs. 6078.HK - Performance Comparison
In the year-to-date period, 1177.HK achieves a -22.77% return, which is significantly lower than 6078.HK's -11.47% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
1177.HK vs. 6078.HK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sino Biopharmaceutical Ltd (1177.HK) and Hygeia Healthcare Holdings Co Ltd (6078.HK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
1177.HK vs. 6078.HK - Dividend Comparison
1177.HK's dividend yield for the trailing twelve months is around 2.99%, more than 6078.HK's 0.52% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1177.HK Sino Biopharmaceutical Ltd | 2.99% | 2.31% | 2.19% | 0.73% | 0.71% | 0.37% | 0.77% | 0.22% | 0.49% | 0.25% | 0.27% | 0.24% |
6078.HK Hygeia Healthcare Holdings Co Ltd | 0.52% | 0.46% | 0.00% | 0.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
1177.HK vs. 6078.HK - Drawdown Comparison
The maximum 1177.HK drawdown since its inception was -87.72%, which is greater than 6078.HK's maximum drawdown of -81.32%. Use the drawdown chart below to compare losses from any high point for 1177.HK and 6078.HK. For additional features, visit the drawdowns tool.
Volatility
1177.HK vs. 6078.HK - Volatility Comparison
The current volatility for Sino Biopharmaceutical Ltd (1177.HK) is 14.02%, while Hygeia Healthcare Holdings Co Ltd (6078.HK) has a volatility of 21.77%. This indicates that 1177.HK experiences smaller price fluctuations and is considered to be less risky than 6078.HK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
1177.HK vs. 6078.HK - Financials Comparison
This section allows you to compare key financial metrics between Sino Biopharmaceutical Ltd and Hygeia Healthcare Holdings Co Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities